lenalidomide mylan
mylan ireland limited - lenalidomidă - mielom multiplu - imunosupresoare - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).
sunitinib mylan 12,5 mg
remedica ltd - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib mylan 25 mg
remedica ltd - cipru - sunitinibum - caps. - 25mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib mylan 37,5 mg
remedica ltd - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib mylan 50 mg
remedica ltd - cipru - sunitinibum - caps. - 50mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 10 mg
synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 2,5 mg
synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 5 mg
synthon hispania sl - spania - everolimus - compr. - 5mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 10 mg
synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 2,5 mg
synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza